Please login to the form below
Aragon Pharma
This page shows the latest Aragon Pharma news and features for those working in and with pharma, biotech and healthcare.
J&J’s Erleada first US drug for non-metastatic prostate cancer
J&J acquired Erleada when it took over Aragon Pharma in 2013 in a deal valued at $1bn.
Latest news
-
J&J completes Aragon deal as Seragon is born
The deal secures a promising new prostate cancer therapy for the pharma major in the form of Aragon's ARN-509, a second generation androgen receptor signalling inhibitor which has reached ... Seragon spun out. The closure of the deal also sees the
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
-
Senior Copywriter
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Spotlight interview: 15 minutes on PR in pharma
- Changing healthcare, one film at a time
- Faisal Ahmed joins healthcare comms agency Sudler London
- Red Consultancy appoints MD in its health division
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Wilmington Healthcare appoints new consultants
PMHub
Star
We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...
Latest intelligence
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
- What is changing in cardiovascular disease care?
- Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
Quick links
Infographics
